Stroke is the second leading cause of death and one of the most important causes of disability in the modern world. Each year, 15 million cases of stroke are diagnosed worldwide, of which 5 million are fatal and another 5 lead to permanent disability. Is stem cell therapy a new opportunity for stroke patients?
Is lstem cell treatmentthe future of therapy for this disease? Researchers from the University of Texas presented the latest research using stem cells, which promises the development of an effective therapy for treating patients after stroke. On VIII. The World Cerebral Stroke Congress in Brazil (10-13.10.2012) presented the results of clinical trials using the latest stem cell therapy in patients up to 19 days after stroke. The research was conducted at the He alth Science Center at Houston (UTHe alth) at the University of Texas (USA).
Stroke: stem cell therapy
Stem cell therapy is the world's only randomized intraarterial clinical trial of the use of intra-arterial stem cells in the treatment of ischemic stroke. Preclinical studies in mice showed that stem cell treatment helped them recover from a stroke. The next step was the therapy (called ALD-401) for the treatment of stroke patients, which focused on the safety and effectiveness of this regenerative therapy, using the patient's own stem cells from the patient's marrow. From day 13 to 19, cells were fed directly into the carotid artery after the stroke. Early test results for the first 10 patients showed no adverse effects, allowing the researchers to extend the study to its intended 100 patients.
-In many diseases that are difficult or impossible to treat, the possibility of using stem cells is being sought. The broadly understood diseases of the nervous system are one of the most active fields where it will be possible to use the regenerative power dormant in cells. The results of research by scientists at the University of Texas suggest that stem cells may promote the regeneration of the brain afterischemic stroke, caused by a clot in the blood vessels of the brain. This is undoubtedly good news, giving hope that we will soon change these disturbing statistics and will be able to help many patients - says Dr. Tomasz Baran from the Polish Stem Cell Bank.